Skip to main content
Log in

Comparative pharmacokinetics of two nifedipine products in capsule form following single oral administration in healthy volunteers

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The pharmacokinetic parameters (AUC, Cmax, Tmax, and t1/2) of nifedipine following single oral administration of a 10 mg capsule of test product were compared to those of the same amount of a reference product. The two products in capsule form were administered according to a randomized two-way crossover design in 22 healthy male volunteers. Nifedipine plasma concentrations were determined using a rapid, sensitive and precise high performance liquid chromatography (HPLC) method with ultraviolet (UV) detection at 235 nm. The parametric 90% confidence intervals of the mean value of the ratio [Myograd® (test product) /Adalat® (reference product)] for pharmacokinetic parameters were 0.90–1.08, 0.80–1.07, and 0.93–1.12 for AUC0⇌∞, Cmax and t1/2, respectively. In each case, values were within the acceptable bioequivalence range of 0.8–1.25. Distribution free point estimate for the difference in expected medians of Tmax of the two products (Myogard®-Adalat®) was 0.00 h with a 90% confidence interval of 0.00–0.13 which is greater than the accepted bioequivalence of ±0.12. The kinetic parameters were comparable to those reported for nifedipine, and no statistically significant differences were found in any of them when comparing the two products by analysis of variance (ANOVA) on log-transformed data. Thus, the two products could be considered bioequivalent regarding absorption rate (Cmax and Tmax), extent of absorption (Cmax and AUC) and elimination (t1/2)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sorkin E.M., Clissold S.P., Brogden R.N. (1985): Nifedipine, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in ischemic, heart disease, hypertension and related cardio-vascular disorders. Drugs, 30, 182–274.

    Article  CAS  PubMed  Google Scholar 

  2. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., Gilman A.G. (1996): Goodman and Gilman, The Pharmacological Basis of Therapeutics, 9th Edn. New York: McGraw Hill, 635–636.

    Google Scholar 

  3. Shaheen O., Zmeili S., Al-Qussuois Y., Arafat T., Mouti H. (1991): Pharmacokinetics and pharmacodynamics of two commercial oral nifedipine products. Int. J. Clin. Pharmacol. Ther. Toxicol., 29, 337–341.

    CAS  PubMed  Google Scholar 

  4. Kleinbloesem C.H., van Brummelen P., Faber H., Danhof M., Vermeulen N.P.E., Breimer D.D. (1984): Variability in nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in man. Biochem. Pharmacol., 33, 3721–3724.

    Article  CAS  PubMed  Google Scholar 

  5. Foster T.S., Hamann S.R., Richards V.R., Bryant P.J., Graves D.A., McAllister R.G. (1983): Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects. J. Clin. Pharmacol., 23, 161–170.

    CAS  PubMed  Google Scholar 

  6. Gutierrez L.M., Lesko L.J., Whipps R., Carliner n., Fisher M. (1986): Pharmacokinetics and pharmacodynamics of nifedipine in patients at steady state. J. Clin. Pharmacol., 26, 587–562.

    CAS  PubMed  Google Scholar 

  7. Bolton S. (1990): Pharmaceutical Statistics, Practical and Clinical Application. New York: Marcel Dekker, 122–128.

    Google Scholar 

  8. El-Sayed Y.M., Niazi E.M., Khidr S.H. (1993): High-performance liquid chromatographic method for the determination of nifedipine in plasma and its use in pharmacokinetic, studies. J. Clin. Pharm. Ther., 18, 325–330.

    Article  CAS  Google Scholar 

  9. Shumaker R. (1986): PKCALC, a basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab. Rev., 17, 331–348.

    Article  CAS  PubMed  Google Scholar 

  10. Sauter R., Steinijans V.W., Diletti E., Böhm A., Schulz H.U. (1992): Presentation of results of bioequivalence studies. Int. J. Clin. Pharmacol. Ther. Toxicol., 30, 233–256.

    CAS  PubMed  Google Scholar 

  11. Schulz H.U., Steinijans V.W. (1991): Striving for standards in bioequivalence assessment: a review. Int. J. Clin. Pharmacol. Ther. Toxicol., 29, 293–298.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rawashdeh, N.M., Battah, A.H., Irshaid, Y.M. et al. Comparative pharmacokinetics of two nifedipine products in capsule form following single oral administration in healthy volunteers. European Journal of Drug Metabolism and Pharmacokinetics 22, 259–264 (1997). https://doi.org/10.1007/BF03189816

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189816

Keywords

Navigation